Simplex Trading
FULC icon

Simplex Trading’s Fulcrum Therapeutics FULC Stock Holding History

Simplex Trading’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$973K Buy
262,900
+171,000
+186% +$642K ﹤0.01% 2758
2026
Q2 		$336K Buy
91,900
+61,400
+201% +$373K ﹤0.01% 4094
2026
Q1 		$234K Buy
30,500
+15,600
+105% +$145K ﹤0.01% 4118
2025
Q4 		$169K Buy
+14,900
New +$152K ﹤0.01% 4407
2025
Q1 		– Sell
-9,900
Closed -$46K – 8860
2024
Q4 		$46K Sell
9,900
-187,600
-95% -$692K ﹤0.01% 5962
2024
Q3 		$705K Buy
197,500
+194,000
+5,543% +$1.44M ﹤0.01% 3248
2024
Q2 		$21K Buy
3,500
+2,500
+250% +$18.9K ﹤0.01% 6850
2024
Q1 		$9K Buy
+1,000
New +$8.93K ﹤0.01% 7671
2023
Q4 		– Sell
-89,700
Closed -$398K – 9135
2023
Q3 		$398K Buy
89,700
+76,500
+580% +$334K ﹤0.01% 3644
2023
Q2 		$43K Buy
13,200
+11,200
+560% +$32.9K ﹤0.01% 5989
2023
Q1 		$5K Sell
2,000
-5,600
-74% -$50.2K ﹤0.01% 8037
2022
Q4 		$55K Buy
7,600
+2,300
+43% +$15K ﹤0.01% 5753
2022
Q3 		$42K Buy
5,300
+2,700
+104% +$19.3K ﹤0.01% 6671
2022
Q2 		$12K Sell
2,600
-16,100
-86% -$157K ﹤0.01% 8119
2022
Q1 		$442K Buy
18,700
+17,900
+2,238% +$253K ﹤0.01% 3990
2021
Q4 		$14K Buy
+800
New +$15.8K ﹤0.01% 8741

Other funds holding FULC

GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Simplex Trading's FULC Position: Q3 2026 in Review

Simplex Trading opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 41,650 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #4929 among its holdings. This is a return to the name: Simplex Trading previously reported a position in FULC as recently as Q1 2026.

Simplex Trading first reported a position in FULC in Q1 2022 and has held it in 15 quarters since. The position peaked at $752K in Q2 2025. 59 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • Simplex Trading held 41,650 shares of Fulcrum Therapeutics worth $154K as of Q3 2026.
  • Fulcrum Therapeutics was a new Simplex Trading position in Q3 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #4929 holding.
  • Simplex Trading first reported a position in Fulcrum Therapeutics in Q1 2022 and has held it in 15 quarters since.
  • Simplex Trading's Fulcrum Therapeutics position peaked at $752K in Q2 2025.
  • 59 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.